JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bigaillon, C.
Right arrow Articles by Spiegel, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bigaillon, C.
Right arrow Articles by Spiegel, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2005, p. 1011, Vol. 43, No. 2
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.2.1011.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Ineffectiveness of the Binax NOW Malaria Test for Diagnosis of Plasmodium ovale Malaria


    LETTER
 Top
 Letter
 References
 
Malaria remains the most dangerous tropical disease for the French troops deployed overseas. In 2003, 768 cases in the French army were declared along with an increase of incidence of 400% in comparison with 2002, mainly due to the Licorne peacekeeping operation in Ivory Coast. In order to ensure fast diagnosis in the field, a rapid immunochromatographic test (NOW malaria test; Binax, Portland, Oreg.) has been provided to military doctors. This test detects the Plasmodium falciparum-specific HRP2 antigen and a panmalarial aldolase common to all species. The assay is sensitive for the detection of P. falciparum (1) and Plasmodium vivax (2) but, in our experience, is poorly sensitive for the detection of Plasmodium ovale, a species involved in cases of malaria among the French troops in western Africa.

Between November 2002 and August 2004, 114 samples from patients presenting a malaria attack were analyzed in the laboratory of the French military hospital of Bégin (Saint-Mande, France). The Plasmodium species identified were P. falciparum (n = 93), P. ovale (n = 12), P. vivax (n = 9), and P. malariae (n = 1). For each specimen, thin and thick blood films, the Binax NOW malaria test, and a specific SYBR green real-time PCR using the Lightcycler instrument (Roche Diagnostics, Meylan, France) were used for diagnosis. This technique is considered the "gold standard" in our laboratory. Sequences used for the design of primers were the 18S RNA genes of the four species (Table 1), which have been previously validated (data not shown). Thin and thick blood films were stained with a rapid coloration set (Diff-Quick; Dade Behring, Newark, Del.) and examined by two experienced microscopists during 20 min. The rapid immunochromatographic test was used according to the manufacturer's recommendations.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Comparison of Binax NOW malaria test versus microscopic examination and PCR

 
Among the 22 patients infected with non-P. falciparum species, 9 were positive for P. vivax, 12 were positive for P. ovale, and 1 was positive for P. malariae by microscopic examination (Table 1). PCR was used to detect all the infections and confirm all microscopic identifications. The Binax NOW malaria test detected all cases of P. vivax infection (9 of 9) but only 3 of the 12 cases of P. ovale infection (25%). The test was positive in the only case of P. malariae infection. With P. falciparum, 89 cases were positive, and two false positives and one false negative were found.

Considering these data, it seems that the Binax NOW malaria test is not reliable for the detection of P. ovale infection. This has been previously described in a study including nine cases of P. ovale infection (2). The inability of the rapid immunochromatographic test to detect P. ovale has been also observed with the ICT Malaria P.f/P.v test (3, 4). The main explanation for the failure of the assay was low parasite density, but in this study all infections due to P. ovale were detected by microscopic examination. The inaccuracy could be due to low production of the aldolase by P. ovale or, as supposed by Mason et al., to regional variations in the genetic determinants of ICT panmalarial antigen (5). In case of suspicion of malaria challenge, the diagnosis of infection with P. ovale must not be elicited, and blood smear examination remains necessary for the elimination of the diagnosis.


    REFERENCES
 Top
 Letter
 References
 

  1. Cavallo, J. D., E. Hernandez, P. Gerome, T. Debord, and R. Le Vagueresse. 1997. Serum HRP-2 antigens and imported Plasmodium falciparum malaria: comparison of ParaSight-F and ICT malaria P.f. Med. Trop. 57:353-356.
  2. Farcas, G. A., K. J. Zhong, F. E. Lovegrove, C. M. Graham, and K. C. Kain. 2003. Evaluation of the Binax NOW ICT test versus polymerase chain reaction and microscopy for the detection of malaria in returned travellers. Am. J. Trop. Med. Hyg. 69:589-592.[Abstract/Free Full Text]
  3. Grobush, M. P., T. Hanscheid, T. Zoller, T. Jelinek, and G. D. Burchard. 2002. Rapid immunochrommatographic malaria antigen detection unreliable for detecting Plasmodium malariae and Plasmodium ovale. Eur. J. Clin. Microbiol. Infect. Dis. 21:818-820.[Medline]
  4. Iqbal, J., N. Khalid, and P. Hira. 2002. Comparison of two commercial assays with expert microscopy for confirmation of symptomatically diagnosed malaria. J. Clin. Microbiol. 40:4675-4678.[Abstract/Free Full Text]
  5. Mason, D. P., F. Kawamoto, K. Lin, A. Laoboonchai, and C. Wongsrichanalai. 2002. A comparison of two rapid field immunochromatographic tests to expert microscopy in the diagnosis of malaria. Acta Trop. 82:51-59.[CrossRef][Medline]
Christine Bigaillon1*
Eléonore Fontan1
Jean-Didier Cavallo1
Eric Hernandez1

Laboratory of Medical Microbiology,1

André Spiegel2
North Department of Epidemiology and Public Health
HIA Bégin
94163 Saint-Mande Cedex, France,2

* Phone: 33 1 43 98 47 33,Fax: 33 1 43 98 53 36,E-mail: hia-begin-biologie{at}worldonline.fr


Journal of Clinical Microbiology, February 2005, p. 1011, Vol. 43, No. 2
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.2.1011.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bigaillon, C.
Right arrow Articles by Spiegel, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bigaillon, C.
Right arrow Articles by Spiegel, A.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS